@article{APS3876,
author = {Xin Hui and Jie Gao and Xin Xie and Naoki Suto and Tsuyoshi Ogiku and Ming-Wei Wang},
title = {A robust homogeneous binding assay for alpha4bold beta2 nicotinic acetylcholine receptor},
journal = {Acta Pharmacologica Sinica},
volume = {26},
number = {10},
year = {2016},
keywords = {},
abstract = {Aim: To develop a homogeneous high-throughput screening (HTS) assay based on scintillation proximity assay (SPA) technology for identification of novel alpha4beta2 nicotinic acetylcholine receptor (nAChR) modulators.
Methods: Membrane preparation of HEK293 cells expressing alpha4beta2 nAChR, [3H]cytisine and wheat germ agglutinin (WGA)-coupled microbeads were used to develop an HTS assay based on SPA technology. This method was validated against a conventional filter binding approach and applied to large-scale screening of a library containing 32 000 synthetic compounds. Intracellular calcium measurement was carried out to verify the bioactivities of the hits found by the SPA assay.
Results: IC50 values of 2 reference compounds (epibatidine and RJR 2403) determined by SPA and filter binding methods were comparable and consistent with those reported elsewhere. A total of 54 compounds, showing more than 60% competitive inhibition on [3H]cytisine binding to alpha4beta2 nAChR, were identified initially following an HTS campaign. Secondary screening confirmed that 17 compounds with novel chemical structures possessed relatively high binding affinity to alpha4beta2 nAChR (Ki50% inhibition on ABT-594-induced calcium mobilization while none showed any agonist activity.
Conclusion: This homogeneous binding assay is a highly efficient, amenable to automation and robust tool to screen potential alpha4beta2 nAChR modulators in an HTS setting. Its application may be expanded to other membrane receptors and ion channels.},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/3876}
}